Document:

EXHIBIT 4.7 

FORM OF
REPRESENTATIVE’S WARRANT 

THE REGISTERED HOLDER OF THIS WARRANT
BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS WARRANT
EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS WARRANT AGREES THAT IT WILL
NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS WARRANT FOR A PERIOD OF ONE HUNDRED
EIGHTY (180) DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I)
CAPITAL GROWTH FINANCIAL, LLC., BATHGATE CAPITAL PARTNERS LLC (“BATHGATE”) OR AN
UNDERWRITER OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE
OFFICER OR PARTNER OF CGF OR BATHGATE OR OF ANY SUCH UNDERWRITER OR SELECTED DEALER. 

WARRANT 
FOR THE PURCHASE OF 

120,000 SHARES OF
COMMON STOCK 
OF 
A4S TECHNOLOGIES, INC.. 

THIS WARRANT IS NOT
EXERCISABLE PRIOR TO _______ , 2005. 

VOID AFTER 5:00 P.M.
MOUNTAIN TIME,__________ , 2009. 

        This
certifies that, in consideration of $100 duly paid by or on behalf of Bathgate Capital
Partners LLC (“Bathgate”) or its assigns (the “Holder”), as registered
owner of this Warrant, to A4S Technologies, Inc. (the “Company”), Holder is
entitled, at any time or from time to time after _____, 2005 [180 days after the effective
date of the registration statement] (the “Commencement Date”), and at or before
 5:00 p.m., Mountain Time,_____ , 2010 (the “Expiration Date”), but not
 thereafter, to subscribe for, purchase and receive, in whole or in part, up to One
Hundred Twenty Thousand (120,000) shares (a “Share”) of the common stock of the
Company (the “Common Stock”). If the Expiration Date is a day on which banking
institutions are authorized by law to close, then this Warrant may be exercised on the
next succeeding day which is not such a day in accordance with the terms herein. During
the period ending on the Expiration Date, the Company agrees not to take any action
that would terminate the Warrant. This Warrant is initially exercisable at $____ per Share
so purchased; provided, however, that upon the occurrence of any of the events specified
in Section 5 hereof, the rights granted by this Warrant, including the exercise
 price per Share and the number of Shares to be received upon such exercise, shall be
adjusted as therein specified. The term “Exercise Price” shall mean the initial
exercise price or the adjusted exercise price, depending on the context. 

SECTION I 
EXERCISE  

        1.01  
Exercise Procedure. In order to exercise this Warrant, the  exercise form
attached hereto must be duly executed and completed and delivered to the Company, together
with this Warrant and payment of the  Exercise Price for the Shares being purchased
payable in cash or by certified  check or official bank check. If the subscription
rights represented hereby shall not be exercised at or before 5:00 p.m., Mountain time, on
the Expiration Date this Warrant shall become and be void without further force or effect,
and all rights represented hereby shall cease and expire. 

        1.02    
Legend. Each certificate for the securities purchased under this Warrant shall bear
a legend as follows unless such securities have been registered under the Securities Act
of 1933, as amended (the “Act”): 

	 	
“The
securities represented by this certificate have not been registered under the Securities
Act of 1933, as amended (the “Act”) or applicable state law. The securities may
not be offered for sale, sold or otherwise transferred except pursuant to an effective
registration statement under the Act, or pursuant to an exemption from registration under
the Act and applicable state law.” 

             
1.03.       
          Conversion Right. In addition to and without limiting the rights of the
          Warrantholder under the terms of the Warrant, the Holder shall have the right
          (the “Conversion Right”) to convert this Warrant or any portion
          thereof into Shares as provided in this Paragraph 2(c) at any time or from time
          to time prior to its expiration. 

         
          (a)       
          Upon exercise of the Conversion Right with respect to a particular number of
          Warrant (the “Converted Warrants”), the Company shall deliver to the
          Holder, without payment by the Holder of any Exercise Price or any cash or other
          consideration, that number of Shares computed using the following formula: 

		
	                  X =     Y(A-B)

                                 A

                  Where:

                  X =     the number of Shares to be issued to the Holder;

                  Y =     the number of Shares to be converted under this Warrant;

                  A =     The average Current Market Price of a Share for the five Trading Days immediately preceding the Conversion Date (as defined

                           below); or, if the Shares are no longer trading as a Share, the combined average of the Current Market Prices of one share of

                           Common Stock and one Warrant for the five Trading Days immediately preceding the Conversion Date (as defined below); and

                  B =     the Share Exercise Price. 
	

For the purpose of this calculation,
the Current Market Price of a Share shall be deemed to be the last sale price of the
security on the primary trading market for the security on the day for which the price is
being calculated. 

         
          (b)       
          No fractional Shares shall be issuable upon exercise of the Conversion Right,
          and if the number of Shares to be issued in accordance with the foregoing
          formula is other than a whole number, the Company shall pay to the Holder an
          amount in cash equal to such fraction multiplied by the Current Market Price. 

         
          (c)       
          The Conversion Right may be exercised by the Holder by the surrender of the
          Warrant at the principal office of the Company or at the office of the
          Company’s stock transfer agent, if any, together with a written statement
          specifying that the Holder thereby intends to exercise the Conversion Right and
          indicating the number of Shares subject to the Warrant which are being
          surrendered on the reverse side of the Warrant, in exercise of the Conversion
          Right. Such conversion shall be effective upon receipt by the Company of the
          Warrant, or on such later date as is specified therein (the “Conversion
          Date”), but not later than the Expiration Date. Certificates for the
          Converted Shares issuable upon exercise of the Conversion Right, together with a
          check in payment of any fractional Warrant Share and, in the case of a partial
          exercise a new Warrant evidencing the Shares remaining subject to the Warrant,
          shall be issued as of the Conversion Date and shall be delivered to the Holder
          within seven (7) days following the Conversion Date. 

-2- 

             1.04.       
          Holder Deemed Holder of Record. Upon receipt of the
          Warrant by the company as described in Paragraph 2(a) or 2(c) above, the Holder
          shall be deemed to be the holder of record of the Shares issuable upon such
          exercise, notwithstanding that the transfer books of the Company may then be
          closed or that certificates representing such Shares may not have been prepared
          or actually delivered to the Holder. 

SECTION II 
TRANSFER 

        2.01.       Restrictions—General.
The registered Holder of this Warrant, by its                acceptance hereof, agrees
that it will not sell, transfer, assign, pledge or                hypothecate this
Warrant for a period of one hundred eighty (180) days following                the
Effective Date to anyone other than (i) Bathgate Capital Partners LLC                (“Bathgate”)
or an underwriter or a selected dealer in connection with                the Offering, or
(ii) a bona fide officer or partner of Bathgate or of any such                underwriter
or selected dealer. On and after the one hundred eightieth day                after the
Effective Date, transfers to others may be made subject to                compliance with or
exemptions from applicable securities laws. In order to                make any permitted
 assignment, the Holder must deliver to the Company the                assignment
form attached  hereto duly executed and completed, together with                the
Warrant and  payment of all transfer taxes, if any, payable in
               connection therewith. The  Company shall within five business days
transfer                this Warrant on  the books of the Company and shall execute
and deliver a                new Warrant or Warrants of like tenor to the appropriate
assignee(s)                 expressly evidencing the right to purchase the aggregate
number of Shares                 purchasable hereunder or such portion of such
number as shall be                contemplated by  any such assignment.  

        2.02.       Restrictions—Securities.
The securities evidenced by this Warrant                shall not be transferred unless
and until (i) the Company has received  the                opinion of counsel for
the Holder that the securities may be transferred                 pursuant to an
exemption from registration under the Act and applicable                state  securities
laws, the availability of which is established to the                reasonable
satisfaction of the Company (the Company hereby agreeing that the                opinion
of  David H. Drennen, Esq. shall be deemed satisfactory evidence of
               the availability of  an exemption), or (ii) a registration statement
or a                post-effective  amendment to  the Registration
Statement relating to such securities has been filed by the  Company and declared
effective by the Securities and Exchange Commission (the  “Commission”) and
compliance with applicable state securities law has been  established. 

SECTION III 
NEW PURCHASE OPTIONS
TO BE ISSUED 

             3.01.       
          Partial Exercise. Subject to the restrictions in Section 3 hereof, this
          Warrant may be exercised or assigned in whole or in part. In the event  of
          the exercise or assignment hereof in part only, upon surrender of this Warrant
          for cancellation, together with the duly executed exercise or assignment
form and funds sufficient to pay any Exercise Price and/or transfer  tax, the Company
shall cause to be delivered to the Holder without charge a new  Warrant of like tenor
to this Warrant in the name of  the Holder evidencing the right of the Holder to
purchase the number of Shares  purchasable hereunder as to which this Warrant has not
been  exercised or assigned. 

-3- 

             3.02.       
          Loss, Theft, Destruction. Upon receipt by the Company of evidence
          satisfactory to it of the loss, theft, destruction or mutilation of this Warrant
          and of reasonably satisfactory indemnification or the posting of a bond, the
          Company shall execute and deliver a new Warrant of like tenor and date. Any such
          new Warrant executed and delivered as a result of such loss, theft, mutilation
          or destruction shall constitute a substitute contractual obligation on the part
          of the Company. 

SECTION IV 
REGISTRATION RIGHTS 

             4.01.       
          Demand Registration.    (a) The Company, upon written demand
          (the “Initial Demand Notice”) of the Holder(s) of at least 51% of the
          Warrants and/or the underlying  Shares and/or the underlying securities
          (the “Majority Holders”), agrees to  register on one occasion,
          all or any portion of the securities
underlying such Warrants, including the Shares, the Warrants, and the Common Stock
underlying the Warrants (collectively,  the “Registrable Securities”). On
such occasion, the Company will file a registration statement or a post-effective
amendment to the Registration Statement covering the Registrable Securities within sixty
days after receipt of the Initial Demand Notice and use its best efforts to have such
registration statement or post-effective amendment declared effective as soon as possible
thereafter. The demand for registration may be made at any time during a period of five
years beginning on the Effective Date. The Company covenants and agrees to give written
notice of its receipt of any Initial Demand Notice by any Holder(s) to all other
registered Holders of the Warrants and/or the Registrable Securities within ten days from
the date of the receipt of any such Initial Demand Notice. 

             (b)       
          The Company shall bear all fees and expenses attendant to registering the
          Registrable Securities, including the expenses of any legal counsel selected by
          the Holders to represent them in connection with the sale of the Registrable
          Securities, but the Holders shall pay any and all underwriting commissions. The
          Company agrees to use its reasonable best efforts to qualify or register the
          Registrable Securities in such states as are reasonably requested by the
           Majority Holder(s); provided, however, that in no event shall the Company
          be  required to register the Registrable Securities in a state in which
          such  registration would cause (i) the Company to be obligated to qualify
          to do  business in such state, or would subject the Company to taxation as
          a foreign  corporation doing business in such jurisdiction or (ii) the
          principal  stockholders of the Company to be obligated to escrow their
          shares of capital  stock of the Company. The Company shall cause any
          registration statement or post-effective amendment filed pursuant to the demand
          rights granted under Section 5.1.1 to remain effective for a period of nine
          consecutive months from the effective date of such registration statement or
          post-effective amendment. 

             4.02.       
          “Piggy-Back” Registration. (a) In addition to the demand right
          of registration, the Holders of the Warrants shall have the right for a period
          of seven years commencing on  the Effective Date, to include the
          Registrable Securities as part of any other  registration of securities
          filed by the Company (other than in connection with a  transaction
          contemplated by Rule 145(a) promulgated under the Act or pursuant to  Form
          S-8); provided, however, that if, in the written opinion of the Company’s
           managing underwriter or underwriters, if any, for such offering, the
          inclusion  of the Registrable Securities, when added to the securities
          being registered by  the Company or the selling stockholder(s), will exceed
          the maximum amount of the  Company’s securities which can be marketed
          (i) at a price reasonably related to  their then current market value, and
          (ii) without materially and adversely  affecting the entire offering, then
          the Company will still be required to  include the Registrable Securities,
          but may require the Holders to agree, in  writing, to delay the sale of all
          or any portion of the Registrable Securities  for a period of 90 days from
          the effective date of the offering, provided,  further, that if the sale of
          any Registrable Securities is so delayed, then the  number of securities to
          be sold by all stockholders in such public offering  during such 90 day
          period shall be apportioned pro rata among all such selling  stockholders,
          including all holders of the Registrable Securities, according to  the
          total amount of securities of the Company owned by said selling
           stockholders, including all holders of the Registrable Securities. 

-4- 

             4.03.       
          Costs of Registration. The Company shall bear all fees and expenses
          attendant to registering the Registrable Securities, including the expenses of
          any legal counsel selected by the Holders to represent them in connection with
          the sale of the Registrable Securities but the Holders shall pay any and all
          underwriting commissions related to the Registrable Securities. In the event of
          such a proposed  registration, the Company shall furnish the then Holders
          of outstanding  Registrable Securities with not less than fifteen days
          written notice prior to  the proposed date of filing of such registration
          statement. Such notice to the Holders shall continue to be given for each
          applicable registration statement filed (during the period in which the Warrant
          is exercisable) by the Company until such time as all of the Registrable
          Securities have been registered and sold. The holders of the Registrable
          Securities shall exercise the “piggy-back” rights provided for herein
          by giving written notice, within ten days of the receipt of the Company’s
          notice of its intention to file a registration statement. The Company shall
          cause any registration statement filed pursuant to the above
          “piggyback” rights to remain effective for at least nine months from
          the date that the Holders of the Registrable Securities are first given the
          opportunity to sell all of such securities. 

             4.04.       
          Damages. Should the registration or the effectiveness thereof required by
           Sections 4.01 and 4.02 hereof be delayed by the Company or the Company
          otherwise fails to comply with such provisions, the Company shall, in addition
          to any  other equitable or other relief available to the Holder(s), be
          liable for any  and all incidental, special and consequential damages
          sustained by the  Holder(s), including, but not limited to, the loss of any
          profits that might  have been received by the Holder upon the sale of
          shares of Common Stock or  Warrants (and shares of Common Stock underlying
          the Warrants) underlying this  Warrant. 

             4.05.       
Indemnification. The Company shall indemnify the Holder(s) of the Registrable
Securities to  be sold pursuant to any registration statement hereunder and
each person, if  any, who controls such Holders within the meaning of
Section 15 of the Act or  Section 20(a) of the Securities Exchange Act of
1934, as amended (the “Exchange  Act”), against all loss, claim,
damage, expense or liability (including all  reasonable attorneys’
fees and other expenses reasonably incurred in  investigating, preparing or
defending against litigation, commenced or  threatened, or any claim
whatsoever whether arising out of any action between  the Underwriter and
the Company or between the Underwriter and any third party  or otherwise)
to which any of them may become subject under the Act, the  Exchange Act or
otherwise, arising from such registration statement but only to  the same
extent and with the same effect as the provisions pursuant to which the
 Company has agreed to indemnify the Underwriters contained in Section 5 of
the  Underwriting Agreement between the Company, Bathgate and the other
Underwriters named therein dated the Effective Date. The Holder(s) of the
 Registrable Securities to be sold pursuant to such registration statement,
and their successors and assigns, shall severally, and not jointly, indemnify
the  Company, its officers and directors and each person, if any, who
controls the  Company within the meaning of Section 15 of the Act or
Section 20(a) of the  Exchange Act, against all loss, claim, damage,
expense or liability (including  all reasonable attorneys’ fees and
other expenses   reasonably incurred in investigating, preparing or
defending against any claim  whatsoever) to which they may become subject
under the Act, the Exchange Act or  otherwise, arising from information
furnished by or on behalf of such Holders,  or their successors or assigns,
in writing, for specific inclusion in such  registration statement to the
same extent and with the same effect as the  provisions contained in
Section 5 of the Underwriting Agreement pursuant to  which the Underwriters
have agreed to indemnify the Company.  

             4.06.       
          No Requirement to Exercise. Nothing contained in this Warrant shall be
          construed as requiring the Holder(s) to exercise their Warrants prior to or
          after the initial filing of any registration statement or the effectiveness
          thereof.     

-5- 

            4.07.       
          Counsel and Accountants. The Company shall furnish Bathgate, as
          representative of  the Holders participating in any of the foregoing
          offerings, a signed  counterpart, addressed to the participating Holders,
          of (i) an opinion of  counsel to the Company, dated the effective date of
          such registration statement  (and, if such registration includes an
          underwritten public offering, an opinion  dated the date of the closing
          under any underwriting agreement related thereto),  and (ii) a “cold
          comfort” letter dated the effective date of such registration
           statement (and, if such registration includes an underwritten public
          offering, a  letter dated the date of the closing under the underwriting
          agreement) signed by  the independent public accountants who have issued a
          report on the Company’s  financial statements included in such
          registration statement, in each case  covering substantially the same
          matters with respect to such registration  statement (and the prospectus
          included therein) and, in the case of such  accountants’ letter, with
          respect to events subsequent to the date of such  financial statements, as
          are customarily covered in opinions of issuer’s counsel  and in
          accountants’ letters delivered to underwriters in underwritten public
           offerings of securities. The Company shall also deliver promptly to
          Bathgate, as representatives of the Holders participating in the offering,
           the correspondence and memoranda described below and copies of all
           correspondence between the Commission and the Company, its counsel or
          auditors  and all memoranda relating to discussions with the Commission or
          its staff with  respect to the registration statement and permit Bathgate,
          as  representatives of the Holders, to do such investigation, upon
          reasonable  advance notice, with respect to information contained in or
          omitted from the  registration statement as it deems reasonably necessary
          to comply with applicable securities laws or rules of the National Association
          of Securities  Dealers, Inc. (the “NASD”). Such investigation
          shall include access to books,  records and properties and opportunities to
          discuss the business of the Company  with its officers and independent
          auditors, all to such reasonable extent and at such reasonable times and as
          often as Bathgate, as representative
of the Holders, shall reasonably request. The Company shall not  be required to
disclose any confidential information or other records to Bathgate, as representative of
the Holders, or to any other  person, until and unless such persons shall have
entered into reasonable  confidentiality agreements (in form and substance reasonably
satisfactory to the  Company), with the Company with respect thereto. 

            4.08.       
          Underwriting Agreement. The Company shall enter into an underwriting
          agreement with the managing underwriter(s), if any, selected by any Holders
          whose Registrable Securities are being registered pursuant to this Section 4,
          which managing underwriter shall be reasonably acceptable to the Company. Such
          agreement shall be reasonably satisfactory in form and substance to the
          Company, each Holder and such managing underwriters, and shall contain such
          representations, warranties and covenants by the Company and such other terms as
          are customarily contained in agreements of that type used by the managing
          underwriter. The Holders shall be parties to  any underwriting agreement
          relating to an underwritten sale of their Registrable  Securities and may,
          at their option, require that any or all the  representations, warranties
          and covenants of the Company to or for the benefit  of such underwriters
          shall also be made to and for the benefit of such Holders.  Such Holders
          shall not be required to make any representations or warranties to or agreements
          with the Company or the underwriters except as they may    relate to
          such Holders and their intended methods of distribution. Such Holders, however,
          shall agree to such covenants and indemnification and contribution obligations
          for selling stockholders as are customarily contained in agreements of that type
          used by the managing underwriter. Further, such Holders shall execute
          appropriate custody agreements and otherwise cooperate fully in the preparation
          of the registration statement and other documents relating to any offering in
          which they include securities pursuant to this Section 4. Each Holder shall also
          furnish to the Company such information regarding itself, the Registrable
          Securities held by it, and the intended method of disposition of such securities
          as shall be reasonably required to affect the registration of the Registrable
          Securities. 

           4.09.       
          Effect of Rule 144. Notwithstanding anything contained in this Section 4
          to the contrary, the  Company shall have no obligation pursuant to Sections
          4(a) or 5(b) for the registration of Registrable Securities held by any Holder
          (i) where such Holder  would then be entitled to sell under Rule 144 within
          any three-month period (or such other period prescribed under Rule 144 as may be
          provided by amendment  thereof) all of the Registrable Securities then held
          by such Holder, and (ii) where the number of Registrable Securities held by such
          Holder is within the volume limitations under paragraph (e) of Rule 144
          (calculated as if such Holder were an affiliate within the meaning of Rule 144). 

-6- 

           4.10.       
          Notice to Company. Each Holder agrees, that upon receipt of any notice
          from the Company of the  happening of any event as a result of which the
          prospectus included in the  Registration Statement, as then in effect,
          includes an untrue statement of a  material fact or omits to state a
          material fact required to be stated therein or  necessary to make the
          statements therein not misleading in light of the  circumstances then
          existing, such Holder will immediately discontinue  disposition of
          Registrable Securities pursuant to the Registration Statement  covering
          such Registrable Securities until such Holder’s receipt of the copies
           of a supplemental or amended prospectus, and, if so desired by the
          Company, such  Holder shall deliver to the Company (at the expense of the
          Company) or destroy  (and deliver to the Company a certificate of such
          destruction) all copies, other  than permanent file copies then in such
          Holder’s possession, of the prospectus covering such Registrable Securities
          current at the time of receipt of such  notice. 

SECTION V 
ADJUSTMENTS 

        The
Exercise Price and number of securities issuable with respect to the Share Warrants shall
be adjusted on the same terms and conditions, and at the same time, as any adjustments in
the Exercise Price and number of shares issuable with respect to the Public Warrants
required by the terms of the Public Warrants. 

           5.01.       
          Exercise Price and Number of Securities. The Exercise Price and the
          number of Shares underlying the Warrant shall be subject to adjustment from time
          to time as hereinafter set forth:     

           (a)       
          If after the date hereof, and subject to the provisions of Section 5.01(c)
          below, the number of outstanding shares of Common Stock is increased by a stock
          dividend payable in shares of Common Stock or by a split-up of shares of Common
          Stock or other similar event, then, on the effective date thereof, the number of
          shares of Common Stock underlying each of the Shares purchasable hereunder and
          under the Warrants shall be increased in proportion to such increase in
          outstanding shares. In such case, the number of shares of Common Stock, and the
          exercise price applicable thereto, underlying the Warrants and underlying
          each of the Warrants purchasable hereunder shall be adjusted in accordance with
          the terms of the Warrants. For example, if the Company declares a
          two-for-one stock dividend and at the time of such dividend this Warrant is for
          the purchase of one Share at $___ per whole Share, upon effectiveness of the
          dividend, this Warrant will be adjusted to allow for the purchase of two (2)
          Shares at $____ per Share and two (2) Warrants at $___ per Warrant. 

           (b)       
          If after the date hereof, and subject to the provisions of Section 5.01(c), the
          number of outstanding shares of Common Stock is decreased by a consolidation,
          combination or reclassification of shares of Common Stock or other similar
          event, then, on the effective date thereof, the number of shares of Common Stock
          underlying each of the Shares purchasable hereunder shall be decreased in
          proportion to such decrease in outstanding shares. In such case, the number of
          shares of Common Stock, and the exercise price applicable thereto, issuable upon
          exercise of the Warrants included in each of the Shares purchasable hereunder
          shall be adjusted in accordance with the terms of the Warrants. 

           (c)       
          In case of any reclassification or reorganization of the outstanding
           shares of Common Stock other than a change covered by Section 6(a)(i) or
           6(a)(ii) hereof or that solely affects the par value of such shares of
          Common  Stock, or in the case of any merger or consolidation of the Company
          with or into  another corporation (other than a consolidation or merger in
          which the Company  is the continuing corporation and that does not result
          in any reclassification  or reorganization of the outstanding shares of
          Common Stock), or in the case of  any sale or conveyance to another
          corporation or entity of the property of the  Company as an entirety or
          substantially as an entirety in connection with which  the Company is
          dissolved, the Holder of this Warrant shall have the  right thereafter
          (until the expiration of the right of exercise of this Warrant) to receive upon
          the exercise hereof, for the same aggregate Exercise
Price payable hereunder immediately prior to such event, the kind and  amount of
shares of stock or other securities or property (including cash)  receivable upon
such reclassification, reorganization, merger or consolidation,  or upon a
dissolution following any such sale or transfer, by a Holder of the  number of shares of Common
Stock of the Company obtainable upon exercise of this  Warrant and the underlying
Warrants immediately prior to such  event; and if any reclassification also results
in a change in shares of Common  Stock covered by Section 6(a)(i) or 6(a)(ii), then
such adjustment shall be made pursuant
to Sections 6(a)(i), 6(a)(ii) and this Section 6(a)(iii). The provisions of this Section
6(a)(iii) shall similarly apply to successive reclassifications, reorganizations, mergers
or consolidations, sales or other transfers. 

-7- 

           (d)       
          This form of Warrant need not be changed because of any change pursuant to this
          Section, and Warrants issued after such change may state the same Exercise Price
          and the same number of Shares as are stated in the Warrants initially issued
          pursuant to this Agreement. The acceptance by any Holder of the issuance of new
          Warrants reflecting a required or permissive change shall not be deemed to waive
          any rights to an adjustment occurring after the Commencement Date or the
          computation thereof. 

           5.02.       
          Substitute Warrant. In case of any consolidation of the Company
           with, or merger of the Company with, or merger of the Company into,
          another  corporation (other than a consolidation or merger which does not
          result in any  reclassification or change of the outstanding Common Stock),
          the corporation  formed by such consolidation or merger shall execute and
          deliver to the Holder a  supplemental Warrant providing that the holder of
          each Warrant then outstanding or to be outstanding shall have the right
           thereafter (until the stated expiration of such Warrant) to  receive,
          upon exercise of such Warrant, the kind and amount of  shares of stock and
          other securities and property receivable upon such  consolidation or
          merger, by a holder of the number of shares of Common Stock of  the Company
          for which such Warrant might have been exercised  immediately prior to such
          consolidation, merger, sale or transfer. Such supplemental Warrant shall provide
          for adjustments which shall be identical to the adjustments provided in Section
          6. The above provision of this Section shall similarly apply to successive
          consolidations or mergers. 

           5.03.       
          Fractional Interests. The Company shall not be required to issue
          certificates representing fractions of shares of Common Stock or Warrants upon
          the exercise of the Warrant, nor shall it be required to issue scrip or pay cash
          in lieu of any fractional interests, it being the intent of the parties that all
          fractional interests shall be eliminated by rounding any fraction up to the
          nearest whole number of Warrants, shares of Common Stock or other securities,
          properties or rights. 

           5.04.       
          Reservation and Listing. The Company shall at all times reserve and keep
           available out of its authorized shares of Common Stock, solely for the
          purpose  of issuance upon exercise of the Warrants or the Warrants
           underlying the Warrant, such number of shares of Common Stock or
           other securities, properties or rights as shall be issuable upon the
          exercise  thereof. The Company covenants and agrees that, upon exercise of
          the Warrants and payment of the Exercise Price therefor, all shares of
           Common Stock and other securities issuable upon such exercise shall be
          duly and  validly issued, fully paid and non-assessable and not subject to
          preemptive  rights of any stockholder. The Company further covenants and
          agrees that upon  exercise of the Warrants underlying the Warrants and
          payment of the  respective Warrant exercise price therefor, all shares of
          Common Stock and other  securities issuable upon such exercise shall be
          duly and validly issued, fully  paid and non-assessable and not subject to
          preemptive rights of any stockholder.  As long as the Warrants shall be
          outstanding, the Company shall use  its best efforts to cause all (i)
          Shares and shares of Common Stock issuable upon  exercise of the Warrants,
          (iii) Warrants issuable upon exercise of  the Warrants and (iv) shares of
          Common Stock issuable upon exercise  of the Warrants included in the Share
          issuable upon exercise of the Warrant to be listed (subject to official notice
          of issuance) on all  securities exchanges (or, if applicable on the Nasdaq
          National Market, SmallCap  Market, OTC Bulletin Board or any successor
          trading market) on which the Shares,  the Common Stock or the Public
          Warrants issued to the public in connection  herewith may then be listed
          and/or quoted. 

-8- 

SECTION VI 
CERTAIN NOTICE
REQUIREMENTS 

           6.01.       
          Right to Notice. Nothing herein shall be construed as conferring upon the
          Holders the right to vote or consent as a stockholder for the election of
          directors or any other matter, or as having any rights whatsoever as a
          stockholder of the Company. If, however, at any time prior to the expiration of
           the Warrants and their exercise, any of the events described in
           Section 5.01 shall occur, then, in one or more of said events, the Company
          shall  give written notice of such event at least fifteen days prior to the
          date fixed  as a record date or the date of closing the transfer books for
          the determination  of the stockholders entitled to such dividend,
          distribution, conversion or  exchange of securities or subscription rights,
          or entitled to vote on such  proposed dissolution, liquidation, winding up
          or sale. Such notice shall specify such record date or the date of the closing
          of the transfer books, as the case may be. Notwithstanding the foregoing, the
          Company shall deliver to each Holder a copy of each notice given to the other
          stockholders of the Company at the same time and in the same manner that such
          notice is given to the stockholders. 

           6.02.       
          Enumerated Events. The Company shall be required to give the notice
           described in this Section 8 upon one or more of the following events: (i)
          if the  Company shall take a record of the holders of its shares of Common
          Stock for the  purpose of entitling them to receive a dividend or
          distribution payable  otherwise than in cash, or a cash dividend or
          distribution payable otherwise  than out of retained earnings, as indicated
          by the accounting treatment of such  dividend or distribution on the books
          of the Company, or (ii) the Company shall  offer to all the holders of its
          Common Stock any additional shares of capital  stock of the Company or
          securities convertible into or exchangeable for shares  of capital stock of
          the Company, or any option, right or warrant to subscribe  therefor, or
          (iii) a dissolution, liquidation or winding up of the Company (other than in
          connection  with a consolidation or merger) or a sale of all or
          substantially all of its  property, assets and business shall be proposed. 

           6.03.       
          Change in Exercise Price. The Company shall, promptly after an event
          requiring a change in the Exercise Price pursuant to Section 5 hereof, send
          notice to the Holders of such event and change (the “Price Notice”).
          The Price Notice shall describe the event causing the change and the method of
          calculating same and shall be certified as being true and accurate by the
          Company’s President and Chief Financial Officer. 

           6.04.       
          Notice Delivery. All notices, requests, consents and other communications
          under this Warrant shall be in writing and shall be deemed to have been duly
          made when hand delivered, or mailed by express mail or private courier service:
          (i) If to the registered Holder of the Warrant, to the address of such Holder as
          shown on the books of the Company, or (ii) If to the Company, to the following
          address or to such other address as the Company may designate by notice to the
          Holders: 

		
	         A4S Technologies, Inc.

         489 N. Denver Avenue

         Loveland, CO  80537

         Attn:  President
	

SECTION VII 
MISCELLANEOUS 

-9- 

      7.01.              Amendments.
The Company and Bathgate may from time to time supplement or                 amend
this Warrant without the approval of any of the Holders in order to                cure
any ambiguity, to correct or supplement any provision contained                 herein
that may be defective or inconsistent with any other provisions                herein, or
to make any other provisions in regard to matters or questions                arising
 hereunder that the Company and Bathgate may deem necessary or
               desirable and  that the Company and Bathgate deem shall not adversely
               affect the interest of  the Holders. All other modifications or
amendments                shall require the written consent of and be signed by the party
against whom                enforcement of the modification or amendment is sought.     

      7.02.              Headings.
The headings contained herein are for the sole purpose of                convenience of
reference, and shall not in any way limit or affect the meaning                or
interpretation of any of the terms or provisions of this Share Purchase
               Warrant.     

      7.03.              Entire
Agreement. This Warrant (together with the other  agreements                and
documents being delivered pursuant to or in connection with this                 Warrant)
constitutes the entire agreement of the parties hereto  with                respect
to the subject matter hereof, and supersedes all prior agreements                 and  

understandings of the parties, oral and written, with respect to the subject  matter hereof.

           7.04.           
          Binding Effect. This Warrant shall inure solely to the benefit of, and
          shall be binding upon, the Holder and the Company and their
          permitted assignees, respective successors, legal representative and
          assigns, and no other person shall have or be construed to have any legal or
          equitable right, remedy or claim under or in respect of or by virtue of this
          Warrant or any provisions herein contained. 

           7.05.          
          Governing Law. This Warrant shall be governed by and construed and
          enforced in accordance with the laws of the State of Colorado, without giving
          effect to conflict of laws. The Company hereby agrees that any action,
           proceeding or claim against it arising out of, or relating in any way to
          this Warrant
shall be brought and enforced in the courts of the State of  Colorado or of the
Shareed States of America for the District of Colorado, and irrevocably submits to such
jurisdiction, which jurisdiction shall be  exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient
forum. Any process  or summons to be served upon the Company may be served by
transmitting a copy  thereof by registered or certified mail, return receipt
requested, postage  prepaid, addressed to it at the address set forth in Section 8
hereof. Such mailing shall be deemed personal service and shall be legal and binding upon
the Company in any action, proceeding or claim. The Company and the Holder agree
 that the prevailing party(ies) in any such action shall be entitled to recover
 from the other party(ies) all of its reasonable attorneys’ fees and expenses
 relating to such action or proceeding and/or incurred in connection with the
 preparation therefor. 

           7.06.  
           
          Waivers. The failure of the Company or the Holder to at any time enforce
          any of the provisions of this Warrant shall not be deemed or construed to be a
          waiver of any such provision, nor to in any way affect the validity of this
          Warrant or any provision hereof or the right of the Company or any Holder to
          thereafter enforce each and every provision of this Warrant. No waiver of any
          breach, non-compliance or non-fulfillment of any of the provisions of this
          Warrant shall be effective unless set forth in a written instrument executed by
          the party or parties against whom or which enforcement of such waiver is sought;
          and no waiver of any such breach, non-compliance or non-fulfillment shall be
          construed or deemed to be a waiver of any other or subsequent breach,
          non-compliance or non-fulfillment. 

           7.07.       
          Counterparts. This Warrant may be executed in one or more counterparts,
          and by the different parties hereto in separate counterparts, each of which
          shall be deemed to be an original, but all of which taken together shall
          constitute one and the same agreement, and shall become effective when one or
          more counterparts has been signed by each of the parties hereto and delivered to
          each of the other parties hereto. 

-10- 

           7.08.       
          Exchange Agreement. As a condition of the Holder’s receipt and
          acceptance of this Warrant, Holder agrees that, at any time prior to the
          complete exercise of this Warrant by Holder, if the Company and Bathgate enter
          into an agreement (the “Exchange Agreement”) pursuant to which they
          agree that all outstanding Warrants will be exchanged for securities or cash or
          a combination of both, then Holder shall agree to such exchange and become a
          party to the Exchange Agreement. 

IN WITNESS WHEREOF, the Company has
caused this Warrant to be signed by its duly authorized officer as of the _______ day of
____________, 2005. 

A4S TECHNOLOGIES, INC. 

		
	By: ______________________________      

Name: ______________________________    

Title: ______________________________
	

-11- 

PURCHASE FORM 

Dated: ___________________________  

The undersigned hereby irrevocably
elects to exercise this Warrant to the extent of purchasing                      Shares
and hereby tenders payment of the exercise price thereof. 

INSTRUCTIONS FOR REGISTRATION OF
STOCK 

		
	Name: ___________________________________________________________ 

                  (Please type or print in block letters)

Address: _________________________________________________________
	

  

ASSIGNMENT FORM 

FOR VALUE RECEIVED,
_______________________________________  , hereby sells, assigns and transfers unto 

Name
____________________________________________________________

                                                                                           (Please
type or print in block letters) 

Address
__________________________________________________________  

the right to purchase Shares of
Tri-S Securities Corporation represented by this Warrant to the extent of_____________
          Shares as to which such right is exercisable and does hereby irrevocably
constitute and appoint _________________________  attorney, to transfer the same on the
books of the Company with full power of substitution in the premises. 

Signature
______________________________            Dated  ___________________________  

Notice: the signature on this
assignment must correspond with the name as it appears upon the face of this Warrant
Certificate in every particular, without alteration or enlargement or any change whatever. 

OPTION CONVERSION
EXERCISE FORM 

Pursuant to Section 1.03of the
Warrant, the Holder hereby irrevocably elects to convert Warrants with respect to Shares
of the Company into ________________ Shares of the Company. A conversion calculation is attached
hereto as Exhibit A-1.  

The undersigned requests that
certificates for such Shares be issued as follows: 

Name:
______________________________________________________________________  

Address:
______________________________________________________________  

Deliver to:
_______________________________________________________________  

and that a new Warrant for the
balance remaining of the Shares, if any, subject to the Warrant be registered in the name
of, and delivered to, the undersigned at the address stated above. 

Signature
________________________________                   Dated ___________________________  

-12- 

Exhibit A-1 
CALCULATION OF SHARE
CONVERSION 

			
	Converted Securities (Y)       

Current Market Price (A)       

Exercise Price (B)             

Converted Shares (X)           

Fractional Converted Shares (1)
	 = 

 = 

 = 

 = 

 =
	  ________________________________

$ ________________________________

$ ________________________________

Y(A-B)/A

   _______________________________

Where:  

X =          the number of Shares to be
issued to the Holder; 

Y =          the number of Shares to be
converted under this Warrant; 

A =          the Current Market Price of
one Share (or, if the Shares are no longer trading, the sum of the Current Market
    Prices of one share of Common Stock and one Warrant);
and 

B =     the Share Exercise
Price. 

     (1)    
          Company to pay for fractional Shares in cash @ $ __________ per Share. 

For the purpose of this calculation,
the Current Market Price of a Share shall be deemed to be the last sale price of the
security on the primary trading market for the security on the day for which the price is
being calculated. 

-13-EXHIBIT 10.1

EXHIBIT 10.1 

EMPLOYMENT AGREEMENT 

        THIS
EMPLOYMENT AGREEMENT (this “Agreement”) is made as
of April 1, 2005, by A4S Technologies, Inc., a Colorado corporation (the
“Employer”), and Michael Siemens, an individual who is a resident of Fort
Collins, Colorado (the “Executive”). 

RECITALS 

        WHEREAS,
the Employer wishes to employ Executive upon the terms and conditions set forth in this Agreement; and

        WHEREAS,
the Employee wishes to be employed upon the terms and conditions set forth herein. 

AGREEMENT 

        The
parties, intending to be legally bound, agree as follows: 

1.     DEFINITIONS 

        For the
purposes of this Agreement, the following terms have the meanings specified or referred to
in this Section 1. 

        “Agreement”
means this Employment Agreement, as amended, restated or otherwise modified from time to
time. 

        “Basic
Compensation” means Salary and Benefits. 

        “Benefits”
is defined in Section 3.2. 

        “Board
of Directors” means the board of directors of the Employer. 

        “Change
in Control” means (a) the acquisition, directly or indirectly, by any person or
group (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934) of
the beneficial ownership of more than 50% of the outstanding securities of the Employer;
(b) a merger or consolidation in which the Employer is not the surviving entity, except
for a transaction the principal purpose of which is to change the state in which the
Employer is incorporated; (c) sale, transfer or other disposition of all or substantially
all of the assets of the Employer; (d) a complete liquidation or dissolution of the
Employer, or (e) any reverse merger in which the Employer is the surviving entity but in
which securities possessing more than 50% of the total combined voting power of the
Employer’s outstanding securities are transferred to a person or persons different
from the person’s holding those securities immediately prior to such merger. 

        “Confidential
Information” means any and all: 

        
          (a)              trade
secrets concerning the business and affairs of the Employer, product
          specifications, data, know-how, formulae, compositions, processes, designs,
          sketches, photographs, graphs, drawings, samples, inventions and ideas, past,
          current, and planned research and development, current and planned
manufacturing           or distribution methods and processes, customer lists, current
and anticipated           customer requirements, price lists, market studies, business
plans, computer           software and programs (including object code and source code),
computer software           and database technologies, systems, structures, and
architectures (and related           formulae, compositions, processes, improvements,
devices, know-how, inventions,           discoveries, concepts, ideas, designs, methods
and information), and any other           information, however documented, that is a
trade secret within the meaning of           the Colorado Trade Secrets Act, as in effect
as of the date hereof and as           amended from time to time.  

        
          (b)              information
concerning the business and affairs of the Employer (which includes           historical
financial statements, financial projections and budgets, historical           and
projected sales, capital spending budgets and plans, the names and           backgrounds
of key personnel and personnel training and techniques and           materials), however
documented; and  

        
          (c)              notes,
analysis, compilations, studies, summaries, and other material prepared           by or
for the Employer containing or based, in whole or in part, on any           information
included in the foregoing.  

        “disability”
is defined in Section 6.2. 

        “Effective
Date” means the date stated in the first paragraph of this Agreement. 

        “Employee
Invention” means any idea, invention, technique, modification, process, or
improvement (whether patentable or not), any industrial design (whether registrable or
not), any mask work, however fixed or encoded, that is suitable to be fixed, embedded or
programmed in a semiconductor product (whether recordable or not), and any work of
authorship (whether or not copyright protection may be obtained for it) created,
conceived, or developed by the Executive, either solely or in conjunction with others,
during the Employment Period, or a period that includes a portion of the Employment
Period, that relates in any way to, or is useful in any manner in the business then being
conducted or proposed to be conducted by the Employer, and any such item created by the
Executive, either solely or in conjunction with others, following termination of the
Executive’s employment with the Employer, that is based upon or uses Confidential
Information. 

        “Employment
Period” means the term of the Executive’s employment under this Agreement. 

        “Fiscal
Year” means the Employer’s fiscal year, as it exists on the Effective Date,
which on the Effective Date is the calendar year. 

 

        “for
cause” is defined in Section 6.3. 

        “for good
reason” is defined in Section 6.4. 

        “person”
means any individual, corporation (including any non-profit corporation), general or
limited partnership, limited liability company, joint venture, estate, trust, association,
organization, or governmental body. 

        “Post-Employment
Period” is defined in Section 8.2. 

        “Proprietary
Items” is defined in Section 7.2(a)(iv). 

        “Salary”
is defined in Section 3.1.  

2. EMPLOYMENT TERMS AND
DUTIES 

        2.1    
Employment.   The Employer hereby employs the Executive, and the Executive hereby
accepts employment by the Employer, upon the terms and conditions set forth in this
Agreement.  

        2.2    
Basic Term.   Subject to the provisions of Section 6, the basic term of
the Executive’s employment under this Agreement will begin on the Effective Date and
end on May 31, 2007.  

        2.3
    
Duties.   The Executive will have such duties as are assigned or delegated to the
Executive by the Board of Directors, and will initially serve as President
of the Employer. The Executive will devote substantially all of his business time,
attention, skill, and energy to the business of the Employer, will use his best efforts
to promote the success of the Employer’s business, and will cooperate fully with the
Board of Directors in the advancement of the best interests of the Employer. Nothing in
this Section 2.3, however, will prevent the Executive from engaging in additional
activities in connection with personal investments and community affairs that are not
inconsistent with the Executive’s duties under this Agreement. In addition, provided
that Executive obtains the advance written consent of the Board of Directors, Executive
may serve on the board of directors of other companies. If the Executive is elected as a
director of the Employer or as a director or officer of any of its affiliates, the
Executive will fulfill his duties as such director or officer without additional
compensation.  

3.     COMPENSATION 

        3.1
    
Salary.   The Executive will be paid an annual salary of $125,000, subject to
adjustment as provided below (the “Salary”), which will be payable in
equal periodic installments according to the Employer’s customary payroll practices,
but no less frequently than monthly.
The Executive agrees that $64,000
of his total Salary will be accrued and not be paid (“Deferred Pay”), until such
time as Employer has closed on an Initial Public Offering (“IPO”) of its
securities, raising gross proceeds of $5,000,000 or more, at which time Executive’s
then total Deferred Pay will be paid out and his Salary thereafter paid on a current
basis. In the event that the IPO as defined above is not closed by July 31, 2005,
Executive shall commence being paid his Salary thereafter on a current basis and the
Deferred Pay amount will be paid upon the next fund raising event of at least $250,000,
unless an alternative agreement is reached between the parties. The Salary may be reviewed
by the Board of Directors, and may be adjusted upward, but not downward in the sole
discretion of the Board of Directors.

  

3 

        3.2
    
Bonus.   The Board of Directors will create a bonus plan for executive officers,
which shall include the Executive. The terms and objectives of the bonus plan will be
determined by the Board of Directors; provided, however, that the bonus plan shall: (a)
provide for quarterly bonuses, with the first measurement quarter to commence October 1,
2005; (b) provide for bonuses to be paid quarterly no later than 45 days after the end of
each quarter, so that the first payment, if any bonus is earned, shall be due on or
before February 14, 2006; and (c) include a provision that if Executive fails to satisfy
the quarterly objectives during any calendar year, the Executive will be paid an annual bonus (reduced
by any quarterly bonuses under 3.2(a) that may have been paid for the four calendar
quarters in question) in an amount equal to at least 50% of his Salary.  

        3.3
    
Benefits.   The Executive will, during the Employment Period, be permitted to
participate in such hospitalization, major medical, and other employee benefit plans of
the Employer that may be in effect from time to time, to the extent the Executive is
eligible under the terms of those plans (collectively, the “Benefits”).  

        3.4
    
Options.   The Executive has been granted options to purchase up to 1,800,000 shares
of the Employer’s common stock at $.209 per share, which vest over a period of four
years, with 25% of the shares vested on each of the first, second, third and fourth
anniversaries of the date of grant. The options have been included in an option agreement
which provides that the options will be exercisable for five years from the date of grant
of October 29, 2004, unless earlier terminated in connection with termination of the
Employee’s employment with the Employer, including any periods under Section 6.6
of this Agreement. The vesting of all outstanding stock options to purchase the Employer’s
stock owned by the Employee shall be accelerated to become immediately exercisable in
full in the event of a Change in Control.  

4.     FACILITIES AND
EXPENSES. 

        The
Employer will furnish the Executive office space, equipment, supplies, and such other
facilities and personnel, as the Employer deems necessary or appropriate for the
performance of the Executive’s duties under this Agreement. The Employer will pay the
Executive’s dues in such professional societies and organizations as the Board of
Directors deems appropriate, and will pay on behalf of the Executive (or reimburse the
Executive for) reasonable expenses incurred by the Executive at the request of, or on
behalf of, the Employer in the performance of the Executive’s duties pursuant to this
Agreement, and in accordance with the Employer’s employment policies, including
reasonable expenses incurred by the Executive in attending conventions, seminars, and
other business meetings, in appropriate business entertainment activities, and for
promotional expenses. The Executive must file expense reports with respect to such
expenses in accordance with the Employer’s policies. All expenses shall be reimbursed
within 30 days of submission of appropriate expense reports. 

        
          (a)              Employer
may from time to time during the term of this Agreement request that           Executive
relocate for the benefit of the Company and;  

        
          (b)              Upon
any request made by Employer, Executive, at his sole discretion shall have           a
minimum of thirty days to decide to accept or reject such relocation request.
          If Executive declines such request and Company either terminates the Agreement,
          or revises substantial terms of the Agreement, then Executive shall have the
          right to terminate the Agreement for Good Reason under Section 6.5 (a), and.  

4 

        
          (c)              If
Company requests Executive to relocate and Executive agree to terms of such
          relocation, then Company shall reimburse Executive for Executive’s
          reasonable out-of-pocket expenses incurred in the relocation.  

     5.    
          VACATIONS AND HOLIDAYS 

        The
Executive will be entitled to four weeks’ paid vacation each Fiscal Year in
accordance with the vacation policies of the Employer in effect for its executive officers
from time to time. Such policies may include provisions for carryover of unused vacation
as well as requirements to secure advance approval for carryover of unused vacation hours.
The Executive will also be entitled to the paid holidays set forth in the Employer’s
policies. If the Executive is unable to perform his duties for physical or mental reasons,
then Employer shall provide Executive with his Basic Compensation until Executive’s
employment is terminated due to the disability of the Executive 

6.     TERMINATION  

        6.1  
Events of Termination.   The Employment Period, the Executive’s Basic
Compensation, and any and all other rights of the Executive under this Agreement or
otherwise as an employee of the Employer will terminate (except as otherwise provided in
this Section 6):  

        
          (a)              upon
the death of the Executive;  

        
          (b)              upon
the disability of the Executive (as defined in Section 6.2)           immediately
upon notice from either party to the other;  

        
          (c)              for
cause (as defined in Section 6.3), as determined by the Board of
          Directors immediately upon notice from the Employer to the Executive, or at
such           later time as such notice may specify;  

        
          (d)              for
good reason (as defined in Section 6.4) upon not less than 30           days’ prior
notice from the Executive to the Employer, which notice           specifies the Executive’s
intent to terminate this Agreement and the           factual basis for such termination,
it being understood that if the Employer can           cure the problem giving rise to
such termination within such 30-day period, the           termination will not occur; or  

        
          (e)              upon
notice by the Board of Directors.  

5 

        6.2  
Definition of “Disability.”   For purposes of Section 6, the
Executive will be deemed to have a “disability” if, for physical or mental
reasons, the Executive is unable to perform the Executive’s duties under this
Agreement for 90 consecutive days, or 120 days during any 12-month period, as determined
in accordance with this Section 6.2. The disability of the Executive will be
determined by a medical doctor selected by written agreement of the Employer and the
Executive upon the request of either party by notice to the other. If the Employer and
the Executive cannot agree on the selection of a medical doctor, each of them will select
a medical doctor and the two medical doctors will select a third medical doctor who will
determine whether the Executive has a disability. The determination of the medical doctor
selected under this Section 6.2 will be binding on both parties. The Executive
must submit to a reasonable number of examinations by the medical doctor making the
determination of disability under this Section 6.2, and the Executive hereby
authorizes the disclosure and release to the Employer of such determination and all
supporting medical records. If the Executive is not legally competent, the Executive’s
legal guardian or duly authorized attorney-in-fact will act in the Executive’s
stead, under this Section 6.2, for the purposes of submitting the Executive to the
examinations, and providing the authorization of disclosure, required under this Section
6.2.  

        6.3  
Definition of “For Cause.”   For purposes of Section 6, the
phrase “for cause”means: (a) the Executive’s material breach of this
Agreement; (b) the Executive’s willful failure to adhere to any written Employer
policy if the Executive has been given a reasonable opportunity to comply with such
policy or cure his failure to comply (which reasonable opportunity must be granted during
the 10-day period preceding termination of this Agreement); (c) the appropriation (or
attempted appropriation) of a material business opportunity of the Employer, including
attempting to secure or securing any personal profit in connection with any transaction
entered into on behalf of the Employer; (d) the misappropriation (or attempted
misappropriation) of any of the Employer’s funds or property; or (e) the conviction
of, the indictment for (or its procedural equivalent), or the entering of a guilty plea
or plea of no contest with respect to, a felony.  

        6.4  
Definition of “For Good Reason.”   For purposes of Section 6,
the phrase “for good reason” means: (a) the Employer’s material breach of
this Agreement; or (b) a material reduction in Executive’s position, duties and
responsibilities from those described in Section 2.3 of this Agreement.  

        6.5  
Termination Pay.   Effective upon the termination of this Agreement during the term
specified in Section 2.2, the Employer will be obligated to pay the Executive (or, in the
event of his death, his designated beneficiary as defined below) only such compensation
as is provided in this Section 6.5, and in lieu of all other amounts and in
settlement and complete release of all claims the Executive may have against the Employer
(as set forth in a valid release of the Employer and its agents and affiliates signed by
the Executive), other than the right, if any, to continue to be employed on a reduced
basis as set forth in Section 6.6. For purposes of this Section 6.5, the
Executive’s designated beneficiary will be such individual beneficiary or trust,
located at such address, as the Executive may designate by notice to the Employer from
time to time or, if the Executive fails to give notice to the Employer of such a
beneficiary, the Executive’s estate. Notwithstanding the preceding sentence, the
Employer will have no duty, in any circumstances, to attempt to open an estate on behalf
of the Executive, to determine whether any beneficiary designated by the Executive is
alive or to ascertain the address of any such beneficiary, to determine the existence of
any trust, to determine whether any person or entity purporting to act as the Executive’s
personal representative (or the trustee of a trust established by the Executive) is duly
authorized to act in that capacity, or to locate or attempt to locate any beneficiary,
personal representative, or trustee.  

6 

        
          (a)    Termination
by the Executive for Good Reason. If the Executive terminates           this
Agreement for good reason, the Employer will pay the Executive the           Executive’s
Salary in periodic installments according to the           Employer’s customary
payroll practices until six months after the date such           termination is
effective.  

        
          (b)    Termination
by the Employer for Cause. If the Employer terminates this           Agreement for
cause, the Executive will be entitled to receive his Salary only           through the
date such termination is effective.  

        
          (c)    Termination
upon Disability. If this Agreement is terminated by either           party as a
result of the Executive’s disability, as determined under Section 6.2, the
Employer will pay the Executive the Executive’s           Salary in periodic
installments according to the Employer’s customary           payroll practices until
six months after the date such termination is effective.  

        
          (d)    Termination
upon Death. If this Agreement is terminated because of the           Executive’s
death, the Executive will be entitled to receive the           Executive’s Salary in
periodic installments according to the           Employer’s customary payroll
practices until six months after the date such           termination is effective.  

        
          (e)    Termination
Upon Notice by the Board of Directors. If the Board of           Directors provides
notice of termination of this Agreement which is not for           cause, then the
Employer will pay the Executive the Executive’s Salary in           periodic
installments according to the Employer’s customary payroll           practices until
six months after the date such termination is effective.  

        
          (f)    Benefits.
The Executive’s accrual of, or participation in plans           providing for, the
Benefits will cease at the effective date of the termination           of this Agreement,
and the Executive will be entitled to accrued Benefits           pursuant to such plans
only as provided in such plans; provided, that, if this           Agreement is terminated
pursuant to Sections 6.1(b), (d) or (e), then the Executive will be
entitled to continue to receive his           Benefits until six months after the date
such termination is effective. The           Executive will receive, as part of his
termination pay pursuant to this           Section 6, compensation for any unused
vacation pay on the date the notice           of termination is given under this
Agreement.  

        
          (g)    Termination
After Change in Control. Notwithstanding the foregoing, if           the Executive’s
employment is terminated pursuant to Section 6.1(d) or           6.1(e) at any time
within 90 days following a Change in Control, then the           Employer will pay the
Executive the Executive’s salary in periodic           installments according to the
Employer’s customary payroll practices until           12 months after the date such
termination is effective and Executive shall be           entitled to receive
Benefits during the same twelve month period.  

        6.6   
Employment on Reduced Basis Post-Termination of Basic Term.   In the event of
termination of Executive’s employment pursuant to Section 6.1(d) or (e) (unless such
termination occurs after a Change in Control), or if Executive remains employed at the
end of the basic term specified in Section 2.2, then Executive shall have the right to
elect to continue to be employed thereafter by the Employer on a reduced basis. If
Executive so elects, Executive’s employment shall be deemed to be continuous with
Employer and the Employment Period and term of this Agreement shall be extended to a date
selected by Executive, but no later than December 31, 2008, subject to early termination
by the Employer solely for an event described in Section 6.1(a), (b) or (c). During this
extended period: (i) the Salary of the Executive shall be reduced to $6,000 per year;
(ii) Executive will not be entitled to the bonus described in Section 3.2 or any benefits
described in Sections 3.3, 4 or 5; (iii) Executive’s options described in Section
3.4, as well as any subsequently issued options to Executive under Company’s
Incentive Stock Option Plan shall continue to be outstanding, unless previously exercised
in full by the Executive; (iv) Executive’s duties shall be limited to providing
consulting services as directed by the Board of Directors which services shall not
require travel by Executive or more than two hours per month of Executive’s time;
and (v) except as provided in this Section 6.6, the other terms and conditions of this
Agreement shall remain in force.  

7 

7.     NON-DISCLOSURE
COVENANT; EMPLOYEE INVENTIONS 

        7.1   Acknowledgments
by the Executive.   The Executive acknowledges that (a) during the
Employment Period and as a part of his employment, the Executive will be afforded access
to Confidential Information; (b) public disclosure of such Confidential Information could
have an adverse effect on the Employer and its business; (c) because the Executive
possesses substantial technical expertise and skill with respect to the Employer’s
business, the Employer desires to obtain exclusive ownership of each Employee Invention,
and the Employer will be at a substantial competitive disadvantage if it fails to acquire
exclusive ownership of each Employee Invention; and (d) the provisions of this Section 7 are
reasonable and necessary to prevent the improper use or disclosure of Confidential
Information and to provide the Employer with exclusive ownership of all Employee
Inventions.  

        7.2   
Agreements of the Executive.   In consideration of the compensation and benefits to
be paid or provided to the Executive by the Employer under this Agreement, the Executive
covenants as follows:  

        
          (a)    Confidentiality.  

	 	        (i)
         During and following the Employment Period, the Executive will hold in
          confidence the Confidential Information and will not disclose it to any person
          except with the specific prior written consent of the Employer or except as
          otherwise expressly permitted by the terms of this Agreement.  

	 	        (ii)          Any
trade secrets of the Employer will be entitled to all of the protections and
          benefits under the Colorado Trade Secrets Act, as in effect on the date hereof,
          and as amended from time to time, and any other applicable law. If any
          information that the Employer deems to be a trade secret is found by a court of
          competent jurisdiction not to be a trade secret for purposes of this Agreement,
          such information will, nevertheless, be considered Confidential Information for
          purposes of this Agreement. The Executive hereby waives any requirement that
the           Employer submit proof of the economic value of any trade secret or post a
bond           or other security.  

8 

	 	        (iii)            None
of the foregoing obligations and restrictions applies to any part of the
          Confidential Information that the Executive demonstrates was or became
generally           available to the public other than as a result of a disclosure by the
Executive.  

	 	        (iv)            The
Executive will not remove from the Employer’s premises (except to the
          extent such removal is for purposes of the performance of the Executive’s
          duties at home or while traveling, or except as otherwise specifically
          authorized by the Employer) any document, record, notebook, plan, model,
          component, device, or computer software or code, whether embodied in a disk or
          in any other form (collectively, the “Proprietary Items”). The
          Executive recognizes that, as between the Employer and the Executive, all of
the           Proprietary Items, whether or not developed by the Executive, are the
exclusive           property of the Employer. Upon termination of this Agreement by
either party, or           upon the request of the Employer during the Employment Period,
the Executive           will return to the Employer all of the Proprietary Items in the
Executive’s           possession or subject to the Executive’s control, and the
Executive shall           not retain any copies, abstracts, sketches, or other physical
embodiment of any           of the Proprietary Items.  

        
          (b)  Employee
Inventions. Until this Agreement is terminated, each Employee           Invention
will belong exclusively to the Employer. The Executive acknowledges           that the
Executive’s writing, works of authorship, and other Employee           Inventions
are works made for hire and the property of the Employer, including           any
copyrights, patents, or other intellectual property rights pertaining           thereto.
The Executive covenants that he will promptly:  

	 	        (i)            disclose
to the Employer in writing any Employee Invention;  

	 	        (ii)            assign
to the Employer or to a party designated by the Employer, at the           Employer’s
request and without additional compensation, all of the           Executive’s right
to the Employee Invention for the United States and all           foreign jurisdictions;  

	 	        (iii)            execute
and deliver to the Employer such applications, assignments, and other           documents
as the Employer may request in order to apply for and obtain patents           or other
registrations with respect to any Employee Invention in the United           States and
any foreign jurisdictions;  

	 	        (iv)            sign
all other papers necessary to carry out the above obligations; and  

	 	        (v)            give
testimony and render any other assistance, without expense to the           Executive, in
support of the Employer’s rights to any Employee Invention.  

        7.3   
Disputes or Controversies.   The Executive recognizes that should a dispute or
controversy arising from or relating to this Agreement be submitted for adjudication to
any court, arbitration panel, or other third party, the preservation of the secrecy of
Confidential Information may be jeopardized. All pleadings, documents, testimony, and
records relating to any such adjudication will be maintained in secrecy and will be
available for inspection by the Employer, the Executive, and their respective attorneys
and experts, who will agree, in advance and in writing, to receive and maintain all such
information in secrecy, except as may be limited by them in writing.  

9 

8.     NON-COMPETITION AND
NON-INTERFERENCE 

        8.1   
Acknowledgments by the Executive.   The Executive acknowledges that: (a) the
services to be performed by him under this Agreement are of a special, unique, unusual,
extraordinary, and intellectual character; (b) the Employer’s business is expected
to be international in scope and its products are expected to be marketed throughout the
world; (c) the Employer competes with other businesses that are or could be located in
any part of the world; and (d) the provisions of this Section 8 are
reasonable and necessary to protect the Employer’s business.  

        8.2   
Covenants of the Executive.   In consideration of the acknowledgments by the
Executive, and in consideration of the compensation and benefits to be paid or provided
to the Executive by the Employer, the Executive covenants that he will not, directly or
indirectly:  

        
          (a)              during
the Employment Period, except in the course of his employment hereunder,           and
during the Post-Employment Period, engage or invest in, own, manage,           operate,
finance, control, or participate in the ownership, management,           operation,
financing, or control of, be employed by, associated with, or in any           manner
connected with, lend the Executive’s name or any similar name to,           lend
Executive’s credit to or render services or advice to, any business           whose
products or activities involve the use of mobile digital video; provided, however,
that the Executive may purchase or otherwise           acquire up to (but not more than)
one percent of any class of securities of any           enterprise (but without otherwise
participating in the activities of such           enterprise) if such securities are
listed on any national or regional securities           exchange or have been registered
under Section 12(g) of the Securities Exchange           Act of 1934;  

        
          (b)              whether
for the Executive’s own account or for the account of any other           person, at
any time during the Employment Period and the Post-Employment Period,           solicit
business of the same or similar type being carried on by the Employer,           from any
person known by the Executive to be a customer of the Employer, whether           or not
the Executive had personal contact with such person during and by reason           of the
Executive’s employment with the Employer;  

        
          (c)              whether
for the Executive’s own account or the account of any other person           (i) at
any time during the Employment Period and the Post-Employment           Period, solicit,
employ, or otherwise engage as an employee, independent           contractor, or
otherwise, any person who is or was an employee of the Employer           at any time
during the Employment Period or in any manner induce or attempt to           induce any
employee of the Employer to terminate his employment with the           Employer; or (ii) at
any time during the Employment Period and for two           years thereafter, interfere
with the Employer’s relationship with any           person, including any person who
at any time during the Employment Period was an           employee, contractor, supplier,
or customer of the Employer; or  

        
          (d)              at
any time during or after the Employment Period, disparage the Employer or any
          of its shareholders, directors, officers, employees, or agents.  

10 

        For
purposes of Section 8.2(a), (b), (c) and (d), the term “Post-Employment
Period”: (i) commences on the date of termination of the Executive’s employment
with the Employer, without regard to the date of employment on a reduced basis under
Section 6.6; and (ii) continues for the six month period thereafter. Provided, that, at
the election of the Employer, such period may be extended for up to 12 additional months
by notice from the Employer to the Executive within 30 days of termination of the
Executive’s employment with the Employer. If Employer exercises this right by
providing timely notice to Executive of Employer’s exercise of this right and the
number of months (not to exceed 12) that Employer has elected to extend the
Post-Employment Period, the Employer shall during each month so extended pay Executive at
a rate equal to the greater of: (i) 66.7% of the Executive’s monthly Salary at
termination; or (ii) the amount payable under Section 6.5 (g); and shall continue for such
period any Benefits the Executive was receiving at termination. Provided, also, that in
the event of termination after a Change in Control, the term “Post-Employment
Period” in this Section 8.2 shall mean the 12-month period beginning on the date of
termination of the Executive’s employment with the Employer and the Employer shall
have no right to further extend the period pursuant to this Section 8.2. 

        If
any covenant in this Section 8.2 is held to be unreasonable, arbitrary, or against
public policy, such covenant will be considered to be divisible with respect to scope,
time, and geographic area, and such lesser scope, time, or geographic area, or all of
them, as a court of competent jurisdiction may determine to be reasonable, not arbitrary,
and not against public policy, will be effective, binding, and enforceable against the
Executive. 

        The
period of time applicable to any covenant in this Section 8.2 will be extended by
the duration of any violation by the Executive of such covenant. 

        The
Executive will, while the covenant under this Section 8.2 is in effect, give notice
to the Employer, within 10 days after accepting any other employment, of the identity of
the Executive’s employer. The Employer may notify such employer that the Executive is
bound by this Agreement and, at the Employer’s election, furnish such employer with a
copy of this Agreement or relevant portions thereof. 

9.     GENERAL PROVISIONS 

        9.1   
Injunctive Relief and Additional Remedy.   The Executive acknowledges that the
injury that would be suffered by the Employer as a result of a breach of the provisions
of this Agreement (including any provision of Sections 7 and 8) would
be irreparable and that an award of monetary damages to the Employer for such a breach
would be an inadequate remedy. Consequently, the Employer will have the right, in
addition to any other rights it may have, to obtain injunctive relief to restrain any
breach or threatened breach or otherwise to specifically enforce any provision of this
Agreement, and the Employer will not be obligated to post bond or other security in
seeking such relief. Without limiting the Employer’s rights under this Section 9 or
any other remedies of the Employer, if the Executive breaches any of the provisions of Section 7
or 8, the Employer will have the right to cease making any payments otherwise
due to the Executive under this Agreement.  

11 

        9.2   
Covenants of Sections 7 and 8 Are Essential and Independent Covenants.   The
covenants by the Executive in Sections 7 and 8 are essential elements
of this Agreement, and without the Executive’s agreement to comply with such
covenants, the Employer would not have entered into this Agreement or employed or
continued the employment of the Executive. The Employer and the Executive have
independently consulted their respective counsel and have been advised in all respects
concerning the reasonableness and propriety of such covenants, with specific regard to
the nature of the business conducted by the Employer.  

        The
Executive’s covenants in Sections 7 and 8 are independent
covenants and the existence of any claim by the Executive against the Employer under this
Agreement or otherwise, will not excuse the Executive’s breach of any covenant in
Section 7 or 8. 

        If
the Executive’s employment hereunder expires or is terminated, this Agreement will
continue in full force and effect as is necessary or appropriate to enforce the covenants
and agreements of the Executive in Sections 7 and 8. 

        9.3   
Offset.   The Employer will be entitled to offset against any and all amounts owing
to the Executive under this Agreement the amount of any and all claims that Employer may
have against the Executive.  

        9.4   
Representations and Warranties by the Executive.   The Executive represents and
warrants to the Employer that the execution and delivery by the Executive of this
Agreement do not, and the performance by the Executive of the Executive’s
obligations hereunder will not, with or without the giving of notice or the passage of
time, or both: (a) violate any judgment, writ, injunction, or order of any court,
arbitrator, or governmental agency applicable to the Executive; or (b) conflict with,
result in the breach of any provisions of or the termination of, or constitute a default
under, any agreement to which the Executive is a party or by which the Executive is or
may be bound.  

        9.5   
Waiver.   The rights and remedies of the parties to this Agreement are cumulative
and not alternative. Neither the failure nor any delay by either party in exercising any
right, power, or privilege under this Agreement will operate as a waiver of such right,
power, or privilege, and no single or partial exercise of any such right, power, or
privilege will preclude any other or further exercise of such right, power, or privilege
or the exercise of any other right, power, or privilege. To the maximum extent permitted
by applicable law, (a) no claim or right arising out of this Agreement can be discharged
by one party, in whole or in part, by a waiver or renunciation of the claim or right
unless in writing signed by the other party; (b) no waiver that may be given by a party
will be applicable except in the specific instance for which it is given; and (c) no
notice to or demand on one party will be deemed to be a waiver of any obligation of such
party or of the right of the party giving such notice or demand to take further action
without notice or demand as provided in this Agreement.  

        9.6   
Binding Effect; Delegation of Duties Prohibited.   This Agreement shall inure to the
benefit of, and shall be binding upon, the parties hereto and their respective
successors, assigns, heirs, and legal representatives, including any entity with which
the Employer may merge or consolidate or to which all or substantially all of its assets
may be transferred. The duties and covenants of the Executive under this Agreement, being
personal, may not be delegated.  

12 

        9.7   
Notices.   All notices, consents, waivers, and other communications under this
Agreement must be in writing and will be deemed to have been duly given when (a)
delivered by hand (with written confirmation of receipt), (b) sent by facsimile (with
written confirmation of receipt), provided that a copy is mailed by registered mail,
return receipt requested, or (c) when received by the addressee, if sent by a nationally
recognized overnight delivery service (receipt requested), in each case to the
appropriate addresses and facsimile numbers set forth below (or to such other addresses
and facsimile numbers as a party may designate by notice to the other parties):  

		
	         If to Employer:       

                               

                               

                               

         If to the Executive:  

                               

                               

                               
	A4S Technologies, Inc.

489 Denver Avenue

Loveland, CO  80537

Fax: (970) 461-0717

Michael Siemens

5402 Old Mill Road

Fort Collins, CO 80528

Fax:

        9.8   
Entire Agreement; Amendments.   This Agreement contains the entire agreement between
the parties with respect to the subject matter hereof and supersedes all prior agreements
and understandings, oral or written, between the parties hereto with respect to the
subject matter hereof, including the Current Agreement. This Agreement may not be amended
orally, but only by an agreement in writing signed by the parties hereto.  

        9.9   
Governing Law.   This Agreement will be governed by the laws of the State of
Colorado without regard to conflicts of laws principles.  

        9.10
   
Jurisdiction.   Any action or proceeding seeking to enforce any provision of, or
based on any right arising out of, this Agreement may be brought against either of the
parties in the courts of the State of Colorado, County of Larimer or, if it has or can
acquire jurisdiction, in the United States District Court located in Denver, Colorado,
and each of the parties consents to the jurisdiction of such courts (and of the
appropriate appellate courts) in any such action or proceeding and waives any objection
to venue laid therein. Process in any action or proceeding referred to in the preceding
sentence may be served on either party anywhere in the world.  

        9.11
   
Section Headings, Construction.   The headings of Sections in this Agreement are
provided for convenience only and will not affect its construction or interpretation. All
references to “Section” or “Sections” refer to the corresponding
Section or Sections of this Agreement unless otherwise specified. All words used in this
Agreement will be construed to be of such gender or number, as the circumstances require.
Unless otherwise expressly provided, the word “including” does not limit the
preceding words or terms.  

13 

        9.12   
Severability.    If any provision of this Agreement is held invalid or unenforceable
by any court of competent jurisdiction, the other provisions of this Agreement will
remain in full force and effect. Any provision of this Agreement held invalid or
unenforceable only in part or degree will remain in full force and effect to the extent
not held invalid or unenforceable.  

        9.13   
Counterparts.    This Agreement may be executed in one or more counterparts, each of
which will be deemed to be an original copy of this Agreement and all of which, when
taken together, will be deemed to constitute one and the same agreement.  

        9.14   
Waiver of Jury Trial.   THE PARTIES HERETO HEREBY WAIVE A JURY TRIAL IN ANY
LITIGATION WITH RESPECT TO THIS AGREEMENT.  

        IN
WITNESS WHEREOF, the parties have executed and delivered this Agreement as of the date
above first written above. 

		
		EMPLOYER:

A4S TECHNOLOGIES, INC.

By: /s/ Thomas R. Marinelli 

Name: Thomas R. Marinelli 

Title: Chief Executive Officer

EXECUTIVE:

/s/ Michael Siemens 

Michael Siemens 

14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]